Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022

Detalles Bibliográficos
Autores principales: Natarajan, Karthik, Prasad, Namrata, Dascomb, Kristin, Irving, Stephanie A., Yang, Duck-Hye, Gaglani, Manjusha, Klein, Nicola P., DeSilva, Malini B., Ong, Toan C., Grannis, Shaun J., Stenehjem, Edward, Link-Gelles, Ruth, Rowley, Elizabeth A., Naleway, Allison L., Han, Jungmi, Raiyani, Chandni, Benitez, Gabriela Vazquez, Rao, Suchitra, Lewis, Ned, Fadel, William F., Grisel, Nancy, Griggs, Eric P., Dunne, Margaret M., Stockwell, Melissa S., Mamawala, Mufaddal, McEvoy, Charlene, Barron, Michelle A., Goddard, Kristin, Valvi, Nimish R., Arndorfer, Julie, Patel, Palak, Mitchell, Patrick K, Smith, Michael, Kharbanda, Anupam B., Fireman, Bruce, Embi, Peter J., Dickerson, Monica, Davis, Jonathan M., Zerbo, Ousseny, Dalton, Alexandra F., Wondimu, Mehiret H., Azziz-Baumgartner, Eduardo, Bozio, Catherine H., Reynolds, Sue, Ferdinands, Jill, Williams, Jeremiah, Schrag, Stephanie J., Verani, Jennifer R., Ball, Sarah, Thompson, Mark G., Dixon, Brian E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979598/
https://www.ncbi.nlm.nih.gov/pubmed/35358170
http://dx.doi.org/10.15585/mmwr.mm7113e2
Descripción
Sumario:

Ejemplares similares